ARANX
Price
$26.45
Change
+$0.01 (+0.04%)
Updated
Nov 19 closing price
Net Assets
1.37B
CLTCX
Price
$15.99
Change
+$0.14 (+0.88%)
Updated
Nov 19 closing price
Net Assets
17.48M
Interact to see
Advertisement

ARANX vs CLTCX

Header iconARANX vs CLTCX Comparison
Open Charts ARANX vs CLTCXBanner chart's image
Horizon Active Risk Assist® Investor
Price$26.45
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets1.37B
Catalyst/Lyons Tactical Allocation C
Price$15.99
Change+$0.14 (+0.88%)
VolumeN/A
Net Assets17.48M
ARANX vs CLTCX Comparison Chart in %
View a ticker or compare two or three
VS
ARANX vs. CLTCX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARANX is a Hold and CLTCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARANX has more cash in the bank: 1.37B vs. CLTCX (17.5M). ARANX pays higher dividends than CLTCX: ARANX (0.47) vs CLTCX (0.00). ARANX was incepted earlier than CLTCX: ARANX (11 years) vs CLTCX (13 years). CLTCX (2.86) is less costly to investors than ARANX (1.28). CLTCX (69.00) and ARANX (66.00) have comparable annual turnover. ARANX (2500) and CLTCX (2500) have matching initial minimum investment requirements. CLTCX annual gain was more profitable for investors over the last year : 5.95 vs. ARANX (-1.30). ARANX return over 5 years is better than : 26.84 vs. CLTCX (-2.93).
ARANXCLTCXARANX / CLTCX
Total Expense Ratio1.282.2856%
Annual Report Gross Expense Ratio1.282.8645%
Fund Existence11 years13 years-
Gain YTD10.07510.29998%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B17.5M7,834%
Annual Yield % from dividends0.470.00-
Returns for 1 year-1.305.95-22%
Returns for 3 years31.589.13346%
Returns for 5 years26.84-2.93-915%
Returns for 10 years43.6710.92400%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA45.470.42
+0.93%
CAVA Group
BMO121.780.05
+0.04%
Bank of Montreal
RLAY6.36-0.15
-2.30%
Relay Therapeutics
NOTV0.82-0.04
-4.13%
Inotiv
ABEO4.20-0.27
-6.14%
Abeona Therapeutics